Tofacitinib Impurity 5

Request For Quotation
Tofacitinib Impurity 5 Suppliers list
Company Name: Standardpharm Co. Ltd.
Tel: 86-714-3992388
Email: overseasales1@yongstandards.com
Products Intro: Product Name:Tofacitinib Impurity 5
Purity:0.99 Package:10mg;25mg;50mg;100mg
Company Name: Shenzhen SUNGENING Bio-Medical Co., Ltd.  
Tel: 0755-28967200 13631290199
Email: wxf@sungening.com
Products Intro: Product Name:Tofacitinib Impurity 5
Purity:99% HPLC or More Package:10MG;25MG;50MG;100MG
Company Name: Jinan blalong chemical co. LTD  
Tel: 2710913286@.com
Email: 1513643261@qq.com
Products Intro: Product Name:TofacitinibImpurity5
CAS:2250243-18-4
Purity:99% HPLC Package:50G;10G;1G;500MG;100MG
Company Name: LangFangshi Zekang Pharma Tech CO.,Itd.  
Tel: 0316-2883536 19333636468
Email: 93618484@qq.com
Products Intro: Product Name:Tofacitinib Impurity 5
CAS:2250243-18-4
Purity:95%+HPLC Package:25mg，50mg，100mg，500mg
Company Name: Nantong Hanfang Biotechnology Co. , Ltd.  
Tel: hanfangpharma@126.com; 18616537568
Email: hanfangpharma@126.com
Products Intro: CAS:2250243-18-4
Purity:98% HPLC Package:10mg;1g;10g;100g;1kg
Tofacitinib Impurity 5 Basic information
Product Name:Tofacitinib Impurity 5
Synonyms:Tofacitinib Impurity 5;3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)-rel-
CAS:2250243-18-4
MF:C13H18ClN5
MW:279.77
EINECS:
Product Categories:
Mol File:2250243-18-4.mol
Tofacitinib Impurity 5 Structure
Tofacitinib Impurity 5 Chemical Properties
density 1.32±0.1 g/cm3(Predicted)
pka13.03±0.50(Predicted)
Safety Information
MSDS Information
Tofacitinib Impurity 5 Usage And Synthesis
Tofacitinib Impurity 5 Preparation Products And Raw materials
Tag:Tofacitinib Impurity 5(2250243-18-4) Related Product Information
Tofacitinib Impurity 6 Tofacitinib Impurity J Tofacitinib Impurity X Tofacitinib Impurity W Tofacitinib Impurity K 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide (3S,4S)-Tofacitinib 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 4 3-(4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine Tofacitinib Impurity I 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE Tofacitinib Impurity 7 Tofacitinib Impurity T